Large-scale testing (Phase 3)Ended earlyNCT04374136
What this trial is testing
Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
Who this might be right for
Frontotemporal Dementia
Alector Inc. 119
Showing 13 of 13 results